Skip to main content
Pharmaco Vigilance
Search form
Search
Home
Perspectives
Case Reports
Focus on
Columns
News
Links
About us
Contacts
News
January 2023
Buprenorphine versus methadone for opioid use disorder in pregnancy
January 2023
GLP-1 receptor agonist-associated tumor adverse events: a real-world study from 2004 to 2021 based on FAERS. Front Pharmacol 2022; DOI:10.3389/fphar.2022.925377
January 2023
Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
August 2023
Impact of 2018 EU risk minimisation measures and revised pregnancy prevention programme on utilisation and prescribing trends of medicinal products containing valproate: an interrupted time series study
December 2022
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure
December 2022
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
December 2022
SARS-CoV-2 Vaccines and Adverse Effects in Gynecology and Obstetrics: The First Italian Retrospective Study
September 2022
Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination
September 2022
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study
September 2022
A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
80.211.154.110